Vanguard Group Inc Delcath Systems, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,110,707 shares of DCTH stock, worth $12.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,110,707
Previous 996,376
11.47%
Holding current value
$12.9 Million
Previous $8.34 Million
20.27%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DCTH
# of Institutions
72Shares Held
7.53MCall Options Held
198KPut Options Held
41.7K-
Aigh Capital Management LLC Baltimore, MD1.78MShares$20.7 Million6.51% of portfolio
-
Vivo Capital, LLC Palo Alto, CA997KShares$11.6 Million1.32% of portfolio
-
Essex Investment Management CO LLC Boston, MA337KShares$3.92 Million0.57% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny312KShares$3.63 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA252KShares$2.93 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $100M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...